Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Reduced non-CpG methylation is a potential epigenetic target after spinal cord injury

Reduced non-CpG methylation is a potential epigenetic target after spinal cord injury

Neural Regeneration Research, 2023 · DOI: https://doi.org/10.4103/1673-5374.371399 · Published: March 15, 2023

Spinal Cord InjuryGenetics

Simple Explanation

This study explores how DNA methylation, an epigenetic mechanism, changes after spinal cord injury (SCI) in mice. The researchers focused on non-CpG methylation, a specific type of DNA modification. They found that non-CpG methylation levels decrease after SCI, suggesting this reduction may play a role in the body's response to the injury. The study identified three distinct stages after SCI based on these methylation patterns: early, intermediate, and late. The research also looked at where these methylation changes occur in the genome and how they might affect gene function, particularly in processes related to nerve regeneration and synaptic connections.

Study Duration
42 days
Participants
24 adult C57BL/6 female mice
Evidence Level
Not specified

Key Findings

  • 1
    Global DNA methylation levels, especially non-CpG methylation, decrease modestly after spinal cord injury in mice.
  • 2
    The non-CpG methylation level was markedly reduced despite accounting for a minor proportion of total methylation abundance.
  • 3
    DNA methylation was implicated in essential functional responses to spinal cord injury, including neuronal synaptic connection creation and axon regeneration.

Research Summary

This study investigated the dynamic alterations of DNA methylation during SCI in mice, identifying reduced non-CpG methylation as an epigenetic target. Global DNA methylation levels decreased modestly following SCI, largely due to a decrease in non-CpG methylation. The research classified stages post-SCI as early, intermediate, and late based on global DNA methylation patterns, with the intermediate stage showing the most significant methylation loss.

Practical Implications

Potential Therapeutic Target

Reduced non-CpG methylation may represent a novel epigenetic target for interventions aimed at promoting recovery after spinal cord injury.

Understanding SCI Mechanisms

The study provides insights into the molecular mechanisms underlying the response to SCI, potentially leading to the development of new treatment strategies.

Temporal Considerations

The identification of distinct stages post-SCI based on methylation patterns highlights the importance of considering the timing of interventions targeting epigenetic modifications.

Study Limitations

  • 1
    Identifying the cell type critical for SCI-induced hypomethylation was a challenge in our investigation
  • 2
    RRBS, which is based on a methylation-sensitive restriction enzyme (Msp1), enriched the cytosine methylation of the CCGG content around in the genome.
  • 3
    RRBS also has another limitation: it cannot be used to discriminate between 5mC and 5hmC, which are mediated by TET protein family members

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury